Caixin
Apr 01, 2023 08:00 AM

Zhejiang Hisun Pharmaceutical Co.,Ltd.’s Net Profit Dropped 3.8% in 2022

Zhejiang Hisun Pharmaceutical Co.,Ltd. (浙江海正药业股份有限公司) (600267.SH) reported a net profit of 491.4 million yuan in 2022, down 3.8% year-on-year.

Meanwhile, the company posted 12 billion yuan in revenue, down 0.8% year-on-year.

At the end of the reporting period, it had 18.8 billion yuan in total assets and 10.4 billion yuan in total liabilities, with a liability-to-asset ratio of 55.6%.

Share this article
Open WeChat and scan the QR code
NEWSLETTERS
Get our CX Daily, weekly Must-Read and China Green Bulletin newsletters delivered free to your inbox, bringing you China's top headlines.

We ‘ve added you to our subscriber list.

Manage subscription
PODCAST
Caixin Deep Dive: Why Singapore Sovereign Fund Sues Chinese EV-Maker Nio
00:00
00:00/00:00